Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 9.

Kletenkov, K; Hoffmann, D; Böni, J; Yerly, S; Aubert, V; Schöni-Affolter, F; Struck, D; Verheyen, J; Klimkait, T (2017). Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors? Journal of Antimicrobial Chemotherapy, 72(3):866-875.

Bader, J; Däumer, M; Schöni-Affolter, F; Böni, J; Gorgievski-Hrisoho, Meri; Martinetti, G; Thielen, A; Klimkait, T (2016). Therapeutic Immune Recovery and Reduction of CXCR4-Tropic HIV-1. Clinical Infectious Diseases, 64(3):295-300.

Bader, J; Schöni-Affolter, F; Böni, Jürg; Gorgievski-Hrisoho, M; Martinetti, G; Battegay, M; Klimkait, T (2016). Correlating HIV tropism with immunological response under combination antiretroviral therapy. HIV Medicine, 17(8):615-622.

Weber, R; Ruppik, M; Rickenbach, M; Spoerri, A; Furrer, H; Battegay, M; Cavassini, M; Calmy, A; Bernasconi, E; Schmid, P; Flepp, M; Kowalska, J; Ledergerber, B; Schmid, P; Schultze, D; Schöni-Affolter, F; Schüpbach, J; Speck, R; Taffé, P; Tarr, P; Telenti, A; Trkola, A; Vernazza, P; Weber, R; Yerly, S (2013). Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Medicine, 14(4):195-207.

Schüpbach, J; Bisset, L R; Gebhardt, M D; Regenass, S; Bürgisser, P; Gorgievski, M; Klimkait, T; Andreutti, C; Martinetti, G; Niederhauser, C; Yerly, S; Pfister, S; Schultze, D; Brandenberger, M; Schöni-Affolter, F; Scherrer, A U; Gunthard, H F (2012). Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infection. BMC Infectious Diseases, 12(88):1471-2334.

Clifford, G M; Lise, M; Franceschi, S; Egger, M; Bouchardy, C; Korol, D; Levi, F; Ess, S; Jundt, G; Wandeler, G; Fehr, J; Schmid, P; Battegay, M; Bernasconi, E; Cavassini, M; Calmy, A; Keiser, O; Schöni-Affolter, F (2012). Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. British Journal of Cancer, 106(3):447-452.

Schöni-Affolter, F; Keiser, O; Mwango, A; Stringer, J; Ledergerber, B; Mulenga, L; Bucher, H C; Westfall, A O; Calmy, A; Boulle, A; Chintu, N; Egger, M; Chi, B H (2011). Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: The effect of the competing risk of death in Zambia and Switzerland. PLoS ONE, 6(12):e27919.

Kenfak-Foguena, A; Schöni-Affolter, F; Bürgisser, P; Witteck, A; Darling, K E A; Kovari, H; Kaiser, L; Evison, J M; Elzi, L; Gurter-De La Fuente, V; Jost, J; Moradpour, D; Abravanel, F; Izpopet, J; Cavassini, M (2011). Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerging Infectious Diseases, 17(6):1074-8.

Schüpbach, J; Bisset, L R; Regenass, S; Bürgisser, P; Gorgievski, M; Steffen, I; Andreutti, C; Martinetti, G; Shah, C; Yerly, S; Klimkait, T; Gebhardt, M; Schöni-Affolter, F; Rickenbach, M (2011). High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease. BMC Infectious Diseases, 11(1):254.

This list was generated on Mon Dec 11 15:53:15 2017 CET.